Filtered By:
Cancer: Leukemia
Drug: Aspirin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 28 results found since Jan 2013.
Low-dose acetylsalicylic acid for cancer prevention considering risk factors: A retrospective cohort study
CONCLUSIONS: Our results suggest that aspirin intake is associated with a reduced incidence of colorectal, pancreatic, and prostate cancers and lymphomas.PMID:37302674 | DOI:10.1016/j.annepidem.2023.06.002
Source: Annals of Epidemiology - June 11, 2023 Category: Epidemiology Authors: D ídac Florensa Jordi Mateo Francesc Solsona Leonardo Galv án Miquel Mesas Ramon Pi ñol Leonardo Espinosa-Leal Pere Godoy Source Type: research
Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis
CONCLUSION: CML patients who start with nilotinib have a higher risk of CAE than those with imatinib. Atherosclerosis caused by the inflammatory response and glycolipid metabolism disorder is the key mechanism of nilotinib cardiotoxicity. Rosuvastatin may be an effective treatment for the cardiotoxicity of nilotinib.PMID:36426222 | PMC:PMC9678945 | DOI:10.3389/fcvm.2022.966182
Source: Atherosclerosis - November 25, 2022 Category: Cardiology Authors: Sicong Li Jinshan He Xinyi Zhang Yuchun Cai Jian Liu Xiaoyan Nie Luwen Shi Source Type: research
Hemorrhages in polycythemia vera and essential thrombocythemia: epidemiology, description, and risk factors, learnings from a large cohort
DISCUSSION: The morbidity and mortality of bleedings in MPN should not be underestimated, and some patients could beneficiate from cytoreduction in order to reducing bleeding risk. Iatrogenic bleedings represent a substantial proportion of bleeding and could be better prevented.PMID:35545123 | DOI:10.1055/a-1849-8477
Source: Thrombosis and Haemostasis - May 11, 2022 Category: Hematology Authors: Christophe Nicol Nadine Ajzenberg Karine Lacut Francis Couturaud Brigitte Pan-Petesch Eric Lippert Jean-Christophe Ianotto Source Type: research
"Vitreous Hemorrhage and Long-Lasting Priapism After COVID-19 m-RNA Based Vaccine: A Case Report"
CONCLUSIONS: Due to the several predisposing factors such as diabetes, aspirin assumption, history of blood dyscrasia and infectious retinitis, the relationship between the acute intraocular bleeding and the BNT162b2 inoculation remains difficult to ascertain in this patient. However, the occurrence of lasting priapism and vitreous hemorrhage within 24 h from the vaccination is a critical event which deserves to be mentioned.PMID:35505605 | DOI:10.1177/11206721221098880
Source: European Journal of Ophthalmology - May 4, 2022 Category: Opthalmology Authors: Barbara Casarini Francesco Bruni Pierangela Rubino Paolo Mora Source Type: research
Treatment and Clinical Endpoints in Polycythemia Vera: Seeking the Best Obtainable Version of the Truth
Blood. 2022 Mar 10:blood.2022015680. doi: 10.1182/blood.2022015680. Online ahead of print.ABSTRACTPolycythemia vera (PV) is a Philadelphia chromosome-negative myeloproliferative neoplasm driven by the JAK2 V617F (or rarely exon 12) mutation. Its natural history can extend over a few decades, and therefore treatment planning is predicated on continual re-assessment of traditional risk features (age, prior thrombosis) to evaluate the need for cytoreduction besides foundational therapy with low-dose aspirin and stringent phlebotomy. Shorter- and longer-term patient goals should be considered in light of several variables such...
Source: Cancer Control - March 10, 2022 Category: Cancer & Oncology Authors: Jason Gotlib Source Type: research
Polycythemia Vera: Rapid Evidence Review
Am Fam Physician. 2021 Jun 1;103(11):680-687.ABSTRACTPolycythemia vera is one of three stem-cell-derived myeloid malignancies commonly known as myeloproliferative neoplasms. It is characterized by erythrocytosis, often with associated leukocytosis and thrombocytosis. It has a significant negative impact on overall mortality and morbidity in the form of arterial and venous clots, symptoms of fatigue and pruritus, and conversion to leukemia and myelofibrosis. The World Health Organization's major diagnostic criteria include an elevated hemoglobin or hematocrit level, abnormal results on bone marrow biopsy, and presence of th...
Source: American Family Physician - June 1, 2021 Category: Primary Care Authors: Steven Fox Leslie Griffin Dominique Robinson Harris Source Type: research
